SLC6A19 Polyklonaler Antikörper

SLC6A19 Polyklonal Antikörper für WB, IHC, Indirect ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human, Maus, Ratte

Anwendung

WB, IHC, Indirect ELISA

Konjugation

Unkonjugiert

Kat-Nr. : 29372-1-PBS

Synonyme

Sodium-dependent neutral amino acid transporter B(0)AT1, HND, B0AT1



Geprüfte Anwendungen

Produktinformation

29372-1-PBS bindet in WB, IHC, Indirect ELISA SLC6A19 und zeigt Reaktivität mit human, Maus, Ratten

Getestete Reaktivität human, Maus, Ratte
Wirt / Isotyp Kaninchen / IgG
Klonalität Polyklonal
Typ Antikörper
Immunogen SLC6A19 fusion protein Ag31076
Vollständiger Name solute carrier family 6 (neutral amino acid transporter), member 19
Berechnetes Molekulargewicht 634 aa, 71 kDa
Beobachtetes Molekulargewicht71 kDa
GenBank-ZugangsnummerBC148801
Gene symbol SLC6A19
Gene ID (NCBI) 340024
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Antigen-Affinitätsreinigung
Lagerungspuffer PBS only
LagerungsbedingungenStore at -80°C. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

SLC6A19, also named as B0AT1, encodes system B(0) transmembrane protein that mediates epithelial resorption of neutral amino acids across the apical membrane in kidney and intestine (PubMed: 15044460). The protein contains 634 amino acids and has 12 predicted transmembrane regions with highly expression in human kidney and small intestine and minimal in pancreas (PubMed: 15286787). The expression of SLC6A19 in intestinal cells depends on angiotensin converting enzyme 2 which is the cellular receptor for SARS-CoV-2 (PubMed: 32132184). Mutations in SLC6A19 cause Hartnup disease (PMID: 15286787, PMID: 15286788).